• CMA accuses four pharmas of anticompetitive behaviour pharmatimes
    May 28, 2019
    Four pharma companies stand accused in the UK of colluding to artificially inflate the price of prescription-only, anti-nausea and dizziness drug prochlorperazine, costing the NHS millions of pounds and breaking competition law.
PharmaSources Customer Service